Hypertrophy of the breasts in a patient treated with indinavir

Clinical Infectious Diseases

Volumn 25, Issue 4, 1997, Pages 937-938

  Herry, Isabelle ^a,b   Bernard, Louis ^b   De Truchis, Pierre ^b   Perronne, Christian ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b CHU de Garches   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; INDINAVIR; LAMIVUDINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BREAST HYPERTROPHY; CASE REPORT; CONDYLOMA; CRYOTHERAPY; FEMALE; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LASER SURGERY; PNEUMOCYSTOSIS; PRIORITY JOURNAL;

EID: 0030763107     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597649     Document Type: Article

References (5)

1. Crixivan (indinavir sulfate) capsules product monograph. West Point, PA: Merck & Co., 1996.
2. Invirase (saquinavir mesylate) capsule product monograph. Nutley, NJ: Roche Laboratories, 1995.
3. Norvir (ritonavir) capsule product monograph. North Chicago, IL: Abbott Laboratories, 1996.
4. Moore N, Biour M, Faux G, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985;2:1056-8.
5. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985;40:111-4.